
Cloud-based, multi-tenant medtech-exclusive eQMS pre-mapped to ISO 13485, FDA QMSR (21 CFR Part 820), EU MDR, and MDSAP, serving medical-device and combination-product manufacturers. Design Inputs/Outputs, V&V, and Risk Controls are modelled as first-class data objects.
Greenlight Guru Quality is a cloud, AWS-hosted eQMS launched in 2013 and marketed as the first eQMS built exclusively for medical device manufacturers. The vendor reports 1,000+ device customers globally. Modules cover document control, training, design controls/DHF, ISO 14971 risk management, CAPA, nonconformance, customer feedback/complaints, supplier management, audits, change control, and a Products/BOM workspace.
Pharma relevance for PharmaSpotter is narrow and specific: drug-device combination products (auto-injectors, prefilled syringes, drug-eluting implants, inhalers, on-body delivery systems). For those use cases, the product's data model centres on the DHF/MDF. A dedicated configuration "Greenlight Guru Combination Products QMS" addresses drug-device combination products subject to 21 CFR Part 4 (CGMP for combination products) and the cross-jurisdiction QSR/CGMP overlap.
For monolithic pharma (finished pharmaceuticals under 21 CFR Part 211, biologics, ATMPs, CDMOs, API manufacturers), the vendor does not market the product. A separate SKU "Greenlight Guru Ultralight" targets early-stage device teams, and a separate product "Greenlight Guru Clinical" handles EDC for clinical trials (runs on Microsoft Azure EU, not AWS).
Multi-tenant SaaS hosted on AWS, accessed via standard web browsers; no on-prem option; no single-tenant option marketed on public pages. Greenlight Guru Clinical is a separate product on Microsoft Azure (EU). Minimum browser versions, SSO/SAML/OIDC support, native mobile apps, and granular API rate limits are not enumerated on public pages.
API maturity: platform supports access to QMS data from "tools your team already uses" but public site does not document REST/GraphQL endpoint scope, pre-built named connectors (Jira, Confluence, ERP, PLM), webhooks, or SDKs in a developer-portal style. Data residency: AWS-hosted; default region and EU/APAC sovereign-cloud options not publicly specified for the QMS. Vendor reports 1,000+ device customers across more than 500 cities on five continents.
No published pricing; a quote requires contacting sales. Subscription model, billed annually, with no perpetual or on-prem option. No free trial; no freemium. Third-party reported deal sizes vary widely: OpenRegulatory reports $25K+ to $35K+ per year for small startups (5-10 people), with a Dec 2025 customer-reported update indicating a Jan 2026 "package separation" potentially leading to +100% price increase without new features. SelectHub reports $600/user/month starting. ITQlick reports $500/user/month (Pro plan) — internally inconsistent. Software Advice reports $20,000+ starting.
Recurring buyer-side signal: "expensive for small teams," "expensive when compared to its competition," and contracts typically multi-year (3-4 years cited in Elsmar forum thread). Validation package (IQ/OQ/PQ) bundled at no additional charge.
Vendor markets "time-to-value in weeks—not months or years," supported by personalized onboarding and an implementation plan led by "Gurus" (medtech-experienced customer-success engineers). Public customer references corroborate sub-90-day go-live for small device companies (G2 review: "mostly implemented in 3 months and fully implemented by 5"). For combination-product manufacturers, implementation is meaningfully longer because both 21 CFR Part 820 design controls and 21 CFR Part 4 streamlined provisions must be reflected.
Services included with licence: implementation, validation package (IQ/OQ/PQ), and Guru-led onboarding bundled. Extended SOP authoring, data migration, change management coaching not publicly priced. Migration tools for legacy systems are not publicly documented; third-party reviewers note "lack of structured data export makes migrating to another eQMS painfully manual" and the inverse likely faces symmetrical friction.
Common implementation pitfalls (reviewer-flagged): limited customization (workflows are prescriptive), English-only UI, Quality Events inflexibility with shared dropdowns across CAPA/NCR/audit/customer feedback, DHF/MDF model mismatch with EU MDR Technical Documentation.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Users praise: (a) medtech-specific opinionation that reduces template-authoring burden ("Greenlight Guru has been instrumental for us moving so quickly through our ISO 13485 certification"); (b) implementation speed ("mostly implemented in 3 months and fully implemented by 5"); (c) responsive Guru-led customer support; (d) bundled validation ("the system comes with a validation package each time a newer version exists is extremely appreciated"); (e) design controls + traceability — risk and DHF unification is the most consistently praised feature.
Users report: (a) limited customization — "If you want a super custom system, this probably isn't for you"; (b) inflexible Quality Events with shared dropdowns across CAPA/NCR/audit/customer feedback; (c) English-only UI — "becomes tricky for international companies"; (d) limited analytics; (e) cost — "expensive for smaller teams," contracts typically 3-4 years; (f) multi-year contractual lock-in and limited structured data export; (g) scripted, impersonal customer service in at least one reviewer's experience. Material risk: reported Jan 2026 "package separation" price restructuring potentially +100% at renewal without new functionality.
Share your experience with Greenlight Guru Quality anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section